The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.
| Image |  |
|---|---|
| Description | scientific article published in March 2018 |
| Author/s |
author: Claudimara Ferini Pacicco Lotfi |
| Publication date | March 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |